Our research maintains a singular focus – the patient.

We seek to ask clinical questions through which we can overcome cancer drug resistance and identify new targets/treatments for patients with cancer. Our research is inherently translational by studying patient samples, linking clinical characteristics, and focusing on patient outcomes with a goal for rapid clinical application.

Our research areas include:

  • Application of novel genomic technologies in patient and clinical trial samples.
  • Answering emerging clinical questions by interrogating existing ‘omic datasets.
  • Evolutionary profiling of tumors over time and in response to therapy.
  • Association of environmental exposures with tumor and microenvironmental features.

Contact Us

BRT Room 512
460 W. 12th Ave.
Columbus, OH 43210